Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00083551
Status:
COMPLETED
Last Update Posted:
2015-11-23
First Post:
2004-05-25
Brief Title:
UARK 98-026 TT II Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy
Sponsor:
University of Arkansas
Organization:
University of Arkansas
Organization Data
Organization:
University of Arkansas
Class:
OTHER
Study ID:
5226
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Arkansas
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Celgene Corporation | INDUSTRY |